Waheed Nadia — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Waheed Nadia has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $221K.

Profile

Waheed Nadia

Nadia Waheed is the Chief Medical Officer at Ocular Therapeutix, Inc., a biotechnology company focused on developing therapies for eye diseases. She has experience in the pharmaceutical industry, particularly in ophthalmology.

RoleChief Medical Officer
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-05OCULOCULAR THERAPEUTIX, INCS — Open-market sale14.8K$8.27$123K
2026-02-24OCULOCULAR THERAPEUTIX, INCS — Open-market sale3.5K$7.74$27K
2026-02-18OCULOCULAR THERAPEUTIX, INCS — Open-market sale7.9K$9.04$71K
2025-08-12OCULOCULAR THERAPEUTIX, INCA — Grant or award40.4K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Waheed Nadia?

Nadia Waheed is the Chief Medical Officer at Ocular Therapeutix, Inc., a biotechnology company focused on developing therapies for eye diseases. She has experience in the pharmaceutical industry, particularly in ophthalmology.…

How many SEC Form 4 filings has Waheed Nadia submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Waheed Nadia been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($221K) across all tracked filings.

Where can I see all of Waheed Nadia's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Waheed Nadia profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.